COVID-19 in children: analysis of the first pandemic peak in England

Objectives To assess disease trends, testing practices, community surveillance, case-fatality and excess deaths in children as compared with adults during the first pandemic peak in England. Setting England. Participants Children with COVID-19 between January and May 2020. Main outcome measures Trends in confirmed COVID-19 cases, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity rates in children compared with adults; community prevalence of SARS-CoV-2 in children with acute respiratory infection (ARI) compared with adults, case-fatality rate in children with confirmed COVID-19 and excess childhood deaths compared with the previous 5 years. Results Children represented 1.1% (1,408/129,704) of SARS-CoV-2 positive cases between 16 January 2020 and 3 May 2020. In total, 540 305 people were tested for SARS-COV-2 and 129,704 (24.0%) were positive. In children aged <16 years, 35,200 tests were performed and 1408 (4.0%) were positive for SARS-CoV-2, compared to 19.1%–34.9% adults. Childhood cases increased from mid-March and peaked on 11 April before declining. Among 2,961 individuals presenting with ARI in primary care, 351 were children and 10 (2.8%) were positive compared with 9.3%–45.5% in adults. Eight children died and four (case-fatality rate, 0.3%; 95% CI 0.07% to 0.7%) were due to COVID-19. We found no evidence of excess mortality in children. Conclusions Children accounted for a very small proportion of confirmed cases despite the large numbers of children tested. SARS-CoV-2 positivity was low even in children with ARI. Our findings provide further evidence against the role of children in infection and transmission of SARS-CoV-2.

[1]  Nick Andrews,et al.  All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  I. Douglas,et al.  COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive case series and case control analysis , 2020, medRxiv.

[3]  Supinda Bunyavanich,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. , 2020, JAMA.

[4]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[5]  S. Ladhani,et al.  Prioritising paediatric surveillance during the COVID-19 pandemic , 2020, Archives of Disease in Childhood.

[6]  R. Isba,et al.  Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020 , 2020, Archives of Disease in Childhood.

[7]  S. Faust,et al.  Children are not COVID-19 super spreaders: time to go back to school , 2020, Archives of Disease in Childhood.

[8]  A. Hale,et al.  A cautionary tale of false-negative nasopharyngeal COVID-19 testing , 2020, IDCases.

[9]  John T Brooks,et al.  Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic , 2020, Emerging infectious diseases.

[10]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[11]  M. Lenge,et al.  Children with Covid-19 in Pediatric Emergency Departments in Italy , 2020, The New England journal of medicine.

[12]  Hsien-Ho Lin,et al.  Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset , 2020, JAMA internal medicine.

[13]  K. Tao,et al.  The characteristics of household transmission of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Kari Stefansson,et al.  Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.

[15]  T. Skoff,et al.  Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[16]  C. Eastin,et al.  Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China , 2020, The Journal of Emergency Medicine.

[17]  Jieyun Zhu,et al.  Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis , 2020, Family Medicine and Community Health Journal.

[18]  A. Zangrillo,et al.  Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency , 2020, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[19]  Giacomo Grasselli,et al.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. , 2020, JAMA.

[20]  N. Curtis,et al.  Coronavirus Infections in Children Including COVID-19 , 2020, The Pediatric infectious disease journal.

[21]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[22]  T. Gudbjartsson,et al.  [Incidence and predictors of prolonged intensive care unit stay after coronary artery bypass in Iceland]. , 2020, Laeknabladid.

[23]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[24]  Filipa Ferreira,et al.  RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions. , 2017, The British journal of general practice : the journal of the Royal College of General Practitioners.

[25]  Richard A. White,et al.  Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  A. Bermingham,et al.  Surveillance and outbreak reports A new laboratory-based surveillance system ( Respiratory DataMart System ) for influenza and other respiratory viruses in England : results and experience from 2009 to 2012 , 2014 .

[27]  D. Fleming,et al.  Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. , 2012, Vaccine.